Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Sell
15
ME Quote, Financials, Valuation and Earnings
Last price:
$3.30
Seasonality move
:
-28.29%
Day range:
$3.07 - $3.31
52-week range:
$2.66 - $19.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.32x
P/B ratio:
0.85x
Volume:
260.4K
Avg. volume:
409.7K
1-year change:
-81.7%
Market cap:
$86.2M
Revenue:
$219.6M
EPS (TTM):
-$69.40
Analysts' Opinion
-
Consensus Rating23andMe Holding has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, 23andMe Holding has an estimated upside of 154.55% from its current price of $3.30.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $3.30.
Fair Value
-
According to the consensus of 2 analysts, 23andMe Holding has 154.55% upside to fair value with a price target of -- per share.
ME vs. S&P 500
-
Over the past 5 trading days, 23andMe Holding has overperformed the S&P 500 by 7.12% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
23andMe Holding does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
23andMe Holding revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter 23andMe Holding reported revenues of $44.1M.
Earnings Growth
-
23andMe Holding has grown year-over-year earnings for 0 quarters straight. In the most recent quarter 23andMe Holding reported earnings per share of -$46.40.
Enterprise value:
-40.4M
EV / Invested capital:
-0.40x
Price / LTM sales:
0.32x
EV / EBIT:
--
EV / Revenue:
-0.21x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
0.31x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$89.9M
Return On Assets:
-123.48%
Net Income Margin (TTM):
-318.39%
Return On Equity:
-214.19%
Return On Invested Capital:
-214.19%
Operating Margin:
-133.71%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $297.6M | $270.2M | $193.3M | $50M | $44.1M | |
| Gross Profit | $138.1M | $123.1M | $89.9M | $21.7M | $22.4M | |
| Operating Income | -$323.8M | -$347.9M | -$270.7M | -$76.5M | -$58.9M | |
| EBITDA | -$288.3M | -$309.5M | -$244.9M | -$68.4M | -$52.2M | |
| Diluted EPS | -$14.40 | -$14.57 | -$69.40 | -$3.17 | -$46.40 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $769.4M | $506.2M | $298M | $188.8M | |
| Total Assets | -- | $903M | $1B | $801.2M | $318.9M | |
| Current Liabilities | -- | $113.6M | $144.9M | $101.6M | $152.8M | |
| Total Liabilities | -- | $243.5M | $221.4M | $176M | $217M | |
| Total Equity | -- | $659.5M | $819.3M | $625.3M | $101.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$205.8M | -$145.9M | -$122M | -$57.1M | -$40.9M | |
| Cash From Investing | -$104M | -$11.8M | -$8M | -$2.8M | -$2.7M | |
| Cash From Financing | $18.5M | $4.1M | $2.4M | $1.6M | $260K | |
| Free Cash Flow | -$215.6M | -$157.7M | -$130.2M | -$59.9M | -$43.6M | |
ME
Sector
Market Cap
$86.2M
$45.9M
Price % of 52-Week High
17.2%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-81.7%
-32.15%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$3.21
200-day SMA
Sell
Level
$7.27
Bollinger Bands (100)
Sell
Level
3.77 - 6.67
Chaikin Money Flow
Sell
Level
-19.9M
20-day SMA
Sell
Level
$3.44
Relative Strength Index (RSI14)
Sell
Level
43.64
ADX Line
Sell
Level
16.28
Williams %R
Neutral
Level
-76.3158
50-day SMA
Sell
Level
$3.91
MACD (12, 26)
Sell
Level
-0.21
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Sell
Level
-15M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-8.6809)
Sell
CA Score
(Annual)
Level (-1.7009)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (8.4881)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
Stock Forecast FAQ
In the current month, ME has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ME average analyst price target in the past 3 months is --.
-
Where Will 23andMe Holding Stock Be In 1 Year?
According to analysts, the consensus estimate is that 23andMe Holding share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About 23andMe Holding?
Analysts are divided on their view about 23andMe Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that 23andMe Holding is a Sell and believe this share price will drop from its current level to --.
-
What Is 23andMe Holding's Price Target?
The price target for 23andMe Holding over the next 1-year time period is forecast to be -- according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is ME A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for 23andMe Holding is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of ME?
You can purchase shares of 23andMe Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase 23andMe Holding shares.
-
What Is The 23andMe Holding Share Price Today?
23andMe Holding was last trading at $3.30 per share. This represents the most recent stock quote for 23andMe Holding. Yesterday, 23andMe Holding closed at $3.30 per share.
-
How To Buy 23andMe Holding Stock Online?
In order to purchase 23andMe Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
